They also want to see how today’s diabetes medicines, like GLP-1 agonists (which help the body make more insulin), affect ...

After assessing several combinations, they settled on dual targets: CD63 and CD9. These tetraspanins are expressed in combination on the surface of EVs, but the cells that secrete the EVs only express ...